Drug name - Klisyri
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8980890 | ALMIRALL | Compositions and methods of treating cell proliferation disorders |
Dec, 2025
(3 years from now) | |
| US8236799 | ALMIRALL | Biaryl compositions and methods for modulating a kinase cascade |
Dec, 2025
(3 years from now) | |
| US7300931 | ALMIRALL | Compositions for treating cell proliferation disorders |
Feb, 2026
(3 years from now) | |
| US7851470 | ALMIRALL | Composition and methods for modulating a kinase cascade |
Feb, 2029
(6 years from now) | |
| US10669236 | ALMIRALL | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide |
Sep, 2038
(15 years from now) | |
| CN103274961A | ALMIRALL | Compounds And Methods For Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| CN103274961B | ALMIRALL | Compounds And Methods For Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| CN101184734A | ALMIRALL | Compound And Method For Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| CN101184734B | ALMIRALL | Compounds And Methods For Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| CN101595084A | ALMIRALL | Biaryl Compositions And Methods For Modulating A Kinase Cascade |
Jun, 2027
(4 years from now) | |
| CN101595084B | ALMIRALL | Biaryl Compositions And Methods For Modulating A Kinase Cascade |
Jun, 2027
(4 years from now) | |
| CN101616915A | ALMIRALL | Composition And Methods For Modulating A Kinase Cascade |
Dec, 2027
(5 years from now) | |
| CN101616915B | ALMIRALL | A Method And Composition Of A Kinase Cascade |
Dec, 2027
(5 years from now) | |
| CN101687798A | ALMIRALL | Process For Preparation Of Compositions For Modulating A Kinase Cascade And Methods Of Use Thereof |
May, 2028
(5 years from now) | |
| CN101687798B | ALMIRALL | Process For Preparing Modified Kinase Cascade Composition And Using Method Thereof |
May, 2028
(5 years from now) | |
| IN339823B | ALMIRALL | Compounds For Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| IN201400549P2 | ALMIRALL | Compounds For Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| IN259746B | ALMIRALL | Compositions And Methods Of Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| IN200702504P2 | ALMIRALL | Compositions And Methods Of Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| EP1836169B1 | ALMIRALL | Compositions And Methods Of Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| EP1836169B9 | ALMIRALL | Compositions And Methods Of Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| EP1836169A2 | ALMIRALL | Compositions And Methods Of Treating Cell Proliferation Disorders |
Dec, 2025
(3 years from now) | |
| EP2041071A2 | ALMIRALL | Biaryl Compositions And Methods For Modulating A Kinase Cascade |
Jun, 2027
(4 years from now) | |
| EP2041071B1 | ALMIRALL | Biaryl Compositions And Methods For Modulating A Kinase Cascade |
Jun, 2027
(4 years from now) | |
| EP2114934B1 | ALMIRALL | Composition And Methods For Modulating A Kinase Cascade |
Dec, 2027
(5 years from now) | |
| EP2114934A1 | ALMIRALL | Composition And Methods For Modulating A Kinase Cascade |
Dec, 2027
(5 years from now) | |
| EP2155681A1 | ALMIRALL | Process For The Preparation Of Compositions For Modulating A Kinase Cascade And Methods Of Use Thereof |
May, 2028
(5 years from now) | |
| EP2155681B1 | ALMIRALL | Process For The Preparation Of Compositions For Modulating A Kinase Cascade And Methods Of Use Thereof |
May, 2028
(5 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10323001 | ALMIRALL | Compositions for modulating a kinase cascade and methods of use thereof |
Dec, 2027
(5 years from now) | |
| US10617693 | ALMIRALL | Methods of treating and/or preventing actinic keratosis |
Mar, 2038
(15 years from now) | |
Drugs and Companies using TIRBANIBULIN ingredient
Treatment: Topical treatment of actinic keratosis of the face or scalp
Dosage: OINTMENT;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1% | OINTMENT;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.